Literature DB >> 30598380

A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.

Jamel P Ortoleva1, Frederick C Cobey2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30598380     DOI： 10.1053/j.jvca.2018.11.025

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  4 in total

1.  Rescue of Nimodipine-Induced Refractory Vasoplegia With Hydroxocobalamin in Subarachnoid Hemorrhage: A Case Report.

Authors:  Katherine M Clifford; Jai Madhok; Nick M Murray; Vibha Mohindra
Journal:  Crit Care Explor       Date:  2020-09-23

2.  Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study.

Authors:  Othmar Kofler; Maximilian Simbeck; Roland Tomasi; Ludwig Christian Hinske; Laura Valentina Klotz; Florian Uhle; Frank Born; Maximilian Pichlmaier; Christian Hagl; Markus Alexander Weigand; Bernhard Zwißler; Vera von Dossow
Journal:  J Clin Med       Date:  2022-02-20       Impact factor: 4.241

3.  Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia.

Authors:  Caitlin C Ten Lohuis; Sarah C Burke; Cooper J Jannuzzo; Nicholas A Barker; Edward P Chen; Laurence W Busse
Journal:  Crit Care Explor       Date:  2022-05-13

4.  Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study.

Authors:  Emily E Naoum; Adam A Dalia; Russel J Roberts; Lauren T Devine; Jamel Ortoleva
Journal:  BMC Anesthesiol       Date:  2022-06-27       Impact factor: 2.376
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.